🎁 Black Friday: up to 50% off of annual plans
OK Biotech Co., Ltd. (TPE:4155)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
15.50
-0.70 (-4.32%)
Nov 20, 2026, 1:30 PM CST

OK Biotech Statistics

Total Valuation

OK Biotech has a market cap or net worth of TWD 1.91 billion. The enterprise value is 2.61 billion.

Market Cap1.91B
Enterprise Value 2.61B

Important Dates

The next estimated earnings date is Friday, March 12, 2027.

Earnings Date Mar 12, 2027
Ex-Dividend Date Oct 20, 2026

Share Statistics

OK Biotech has 122.95 million shares outstanding. The number of shares has decreased by -1.34% in one year.

Current Share Class 122.95M
Shares Outstanding 122.95M
Shares Change (YoY) -1.34%
Shares Change (QoQ) +4.62%
Owned by Insiders (%) 5.07%
Owned by Institutions (%) 0.35%
Float 87.29M

Valuation Ratios

The trailing PE ratio is 7.85.

PE Ratio 7.85
Forward PE n/a
PS Ratio 1.11
PB Ratio 0.77
P/TBV Ratio 0.94
P/FCF Ratio 7.23
P/OCF Ratio 3.87
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.77, with an EV/FCF ratio of 9.89.

EV / Earnings 10.39
EV / Sales 1.51
EV / EBITDA 6.77
EV / EBIT 8.81
EV / FCF 9.89

Financial Position

The company has a current ratio of 2.03, with a Debt / Equity ratio of 0.42.

Current Ratio 2.03
Quick Ratio 1.38
Debt / Equity 0.42
Debt / EBITDA 2.79
Debt / FCF 4.05
Interest Coverage 33.08

Financial Efficiency

Return on equity (ROE) is 10.73% and return on invested capital (ROIC) is 7.55%.

Return on Equity (ROE) 10.73%
Return on Assets (ROA) 6.24%
Return on Invested Capital (ROIC) 7.55%
Return on Capital Employed (ROCE) 8.63%
Weighted Average Cost of Capital (WACC) 3.81%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover 0.43
Inventory Turnover 2.57

Taxes

In the past 12 months, OK Biotech has paid 57.81 million in taxes.

Income Tax 57.81M
Effective Tax Rate 17.61%

Stock Price Statistics

The stock price has decreased by -6.13% in the last 52 weeks. The beta is 0.24, so OK Biotech's price volatility has been lower than the market average.

Beta (5Y) 0.24
52-Week Price Change -6.13%
50-Day Moving Average 16.63
200-Day Moving Average 16.19
Relative Strength Index (RSI) 40.72
Average Volume (20 Days) 1,362,763

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, OK Biotech had revenue of TWD 1.72 billion and earned 251.03 million in profits. Earnings per share was 1.97.

Revenue1.72B
Gross Profit 546.74M
Operating Income 293.08M
Pretax Income 328.30M
Net Income 251.03M
EBITDA 369.15M
EBIT 293.08M
Earnings Per Share (EPS) 1.97
Full Income Statement

Balance Sheet

The company has 424.35 million in cash and 1.07 billion in debt, with a net cash position of -643.87 million or -5.24 per share.

Cash & Cash Equivalents 424.35M
Total Debt 1.07B
Net Cash -643.87M
Net Cash Per Share -5.24
Equity (Book Value) 2.52B
Book Value Per Share 19.12
Working Capital 775.95M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 492.52 million and capital expenditures -228.96 million, giving a free cash flow of 263.56 million.

Operating Cash Flow 492.52M
Capital Expenditures -228.96M
Depreciation & Amortization 76.08M
Net Borrowing -77.30M
Free Cash Flow 263.56M
FCF Per Share 2.14
Full Cash Flow Statement

Margins

Gross margin is 31.73%, with operating and profit margins of 17.01% and 14.57%.

Gross Margin 31.73%
Operating Margin 17.01%
Pretax Margin 19.05%
Profit Margin 14.57%
EBITDA Margin 21.43%
EBIT Margin 17.01%
FCF Margin 15.30%

Dividends & Yields

This stock pays an annual dividend of 0.33, which amounts to a dividend yield of 2.16%.

Dividend Per Share 0.33
Dividend Yield 2.16%
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio 0.00%
FCF Payout Ratio 67.96%
Buyback Yield 1.34%
Shareholder Yield 3.50%
Earnings Yield 12.74%
FCF Yield 13.83%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside
Graham Formula Value
Graham Formula Upside

Stock Splits

The last stock split was on October 19, 2026. It was a reverse split with a ratio of 0.89631574.

Last Split Date Oct 19, 2026
Split Type Reverse
Split Ratio 0.89631574

Scores

OK Biotech has an Altman Z-Score of 1.77 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.77
Piotroski F-Score 6